PDF herunterladen
CC BY-NC-ND 4.0 · South Asian J Cancer 2012; 01(02): 56-57
DOI: 10.4103/2278-330X.103708
Mini Symposium on Changing Landscape: Editorial

Using p53 to help diagnose ovarian cancer

Shweta Bansal
Department of medical oncology, SL Raheja Hospital, A Fortis Associated Hospital, Mumbai
› Institutsangaben Source of Support: Nil.
› Weitere Informationen
Auch verfügbar auf
  als PDF herunterladen Lizenzen und Reprints


Publikationsverlauf

Artikel online veröffentlicht:
30. Dezember 2020

© 2012. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Choudhary M, Goyal S, Pujani M, et al. A cytohistological study of p53 over expression in ovarian neoplasms. South Asian J Cancer 2012; 2: 58-61.
  • 2 Bode AM. Too much of a good thing? Trends Endocrinol Metab 2002;13:139-40.
  • 3 Vousden KH, Lu X. Live or let die: The cell′s response to p53. Nat Rev Cancer 2002;2:594-604.
  • 4 Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002;415:45-53.